Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions have?

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions has 286 citations in the OpenAlex counts ScholarIQ stores.

When was Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions published?

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions has 2018 year in the ScholarIQ index.

What is the open-access status of Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions?

Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions has bronze oa status in the ScholarIQ index.

What is the DOI of Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions?

The DOI for Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions is on the source record.

What is the PMID of Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions?

The PMID for Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions is on the source record.

What is the OpenAlex record for Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions?

The OpenAlex for Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions is on the source record.